Chirife et al. (24) reported Ki67 as a predictor of bladder tumor progression in patients undergoing initial transurethral resection, and a meta-analysis by He et al. (6) found a statistically significant correlation between the overexpression of Ki67 and shorter progression-free survival. Here, MKI67 is linked to urinary bladder neoplasm.